Search results for " Oligonucleotide therapeutics"
Article
The oligonucleotide synthesis process consists of a repetitive four-step cycle
The oligo therapeutics market is growing in promise for treating cancers, genetic diseases, and other conditions. In this animated video you can watch the oligonucleotide synthesis process as …
Article
Oligonucleotide manufacturing: how to get a strong start
Oligonucleotide therapeutics have huge potential for transforming human health. If you’re a small biotech or lab developing such therapies, playing the long game is crucial to successful in-ho…
Article
Key Process Considerations for Therapeutic Oligonucleotides
Click here to read the article >>
Learn more about scalable solutions for developing and manufacturing oligonucleotide therapeutics.
Article
Oligonucleotide Therapeutics Heading for Tons of Quantity in Annual Supply Need
Click here to read the full article >>
Solid-phase flow through technology poised to annually produce metric tons (1000 kg) provides the oligonucleotide therapeutic industry efficient synthesis t…
Article
Developing oligonucleotide therapeutics with confidence
In this video, we will look at key considerations for oligo therapeutic developers entering the market, such as scalability, flexibility, regulatory concerns, insource/outsource consideratio…
Article
Get a strong start in oligonucleotide manufacturing
Oligonucleotide therapeutics hold incredible promise. How can you harness their full potential? When starting process development, you need to know where to focus, and you need a scalable a…
Article
Oligonucleotide Development and Manufacturing Workflow
Click here to view >>
Learn more on key considerations when setting up an oligonucleotide workflow with this infographic.
Article
Get to know: oligonucleotide synthesis workflow
This free interactive course introduces you to synthetic oligonucleotides, applications they’re used in, and how they’re synthesized.
Take the course now
Article
Top Process Development Trends for 2021 and a Look into 2022
The COVID-19 pandemic continues to shape bioprocess development trends, and many lessons have been learned from industry’s response to and preparedness for dealing with a public health crisis. Howev…
Article
How can you harness the potential of nucleic acid therapeutics?
At Cytiva, the new team is here to support you. We can help you throughout the
development of your manufacturing workflow for oligonucleotides
and the purification of mRNA drug subs…